
Drug firm Zydus Cadila on Wednesday said it has started human clinical trials of its Covid-19 vaccine candidate ZyCoV-D.
New Delhi: Drug firm Zydus Cadila on Wednesday said it has started human clinical trials of its Covid-19 vaccine candidate ZyCoV-D.
Covid-19 vaccineIn the phase of trials, the company will be enrolling over 1,000 subjects across multiple clinical study sites in India.
The adaptive phase I/ II human clinical trials of ZyCoV-D have commenced with the first human dosing, it said.
Earlier this month, Zydus had received approval from domestic authorities to start human trials for its Covid-19 vaccine contender.
CoronavirusIt got approval a few days after India's first indigenous Covid-19 vaccine candidate COVAXIN, got the nod for human clinical trials from the Drug Controller General of India.